Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Lindy Dickson-Hall"'
Autor:
Jennifer Furin, Marian Loveday, Sindisiwe Hlangu, Lindy Dickson-Hall, Sacha le Roux, Mark Nicol, Helen Cox
Publikováno v:
BMC Public Health, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background Patient-centered care is pillar 1 of the “End TB” strategy, but little has been documented in the literature about what this means for people living with rifampicin-resistant (RR-TB). Optimizing care for such individuals requi
Externí odkaz:
https://doaj.org/article/c234465dbe1d486496610e16c928b6b1
Autor:
Helen Cox, Lindy Dickson-Hall, Norbert Ndjeka, Anja Van't Hoog, Alison Grant, Frank Cobelens, Wendy Stevens, Mark Nicol
Publikováno v:
PLoS Medicine, Vol 14, Iss 2, p e1002238 (2017)
BackgroundSouth Africa has a large burden of rifampicin-resistant tuberculosis (RR-TB), with 18,734 patients diagnosed in 2014. The number of diagnosed patients has increased substantially with the introduction of the Xpert MTB/RIF test, used for tub
Externí odkaz:
https://doaj.org/article/483833597afc468ba1a1a144cf5a5f55
Autor:
Sacha le Roux, Sindisiwe Hlangu, Marian Loveday, Lindy Dickson-Hall, Helen Cox, Mark P. Nicol, Jennifer Furin
Publikováno v:
BMC Public Health, Vol 20, Iss 1, Pp 1-11 (2020)
BMC Public Health
BMC Public Health
Background Patient-centered care is pillar 1 of the “End TB” strategy, but little has been documented in the literature about what this means for people living with rifampicin-resistant (RR-TB). Optimizing care for such individuals requires a bet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aef0bf5b39cfc3761e5190cc85318328
https://doaj.org/article/c234465dbe1d486496610e16c928b6b1
https://doaj.org/article/c234465dbe1d486496610e16c928b6b1
Autor:
Mosa Moshabela, Helen Cox, Marian Loveday, S Le Roux, John Black, Koleka Mlisana, Karina Kielmann, Alison D. Grant, Jeremy Hill, L. Mitrani, Mark P. Nicol, Lindy Dickson-Hall
Publikováno v:
Public Health Action
To describe the medical, socio-economic and geographical profiles of patients with rifampicin-resistant TB (RR-TB) and the implications for the provision of patient-centred care.Thirteen districts across three South African provinces.This descriptive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8000c0fd859f3d531ca2307ad0034e0
https://researchonline.lshtm.ac.uk/id/eprint/4660608/1/Mitrani_etal_2021-Diverse-clinical-and-social-circumstances.pdf
https://researchonline.lshtm.ac.uk/id/eprint/4660608/1/Mitrani_etal_2021-Diverse-clinical-and-social-circumstances.pdf
Autor:
Jeremy Hill, Karina Kielmann, Waasila Jassat, Koleka Mlisana, Marian Loveday, Mark P. Nicol, Mosa Moshabela, Helen Cox, Sacha le Roux, John Black, Alison D. Grant, Lindy Dickson-Hall
Publikováno v:
Health Policy and Planning
In 2011, the South African National TB Programme launched a policy of decentralized management of drug-resistant tuberculosis (DR-TB) in order to expand the capacity of facilities to treat patients with DR-TB, minimize delays to access care and impro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::634a817a09b7aef279ab387d98ec5f86
https://pubmed.ncbi.nlm.nih.gov/33582787
https://pubmed.ncbi.nlm.nih.gov/33582787
Autor:
Karina Kielmann, Koleka Mlisana, Mosa Moshabela, S Le Roux, Waasila Jassat, L. Mitrani, Marian Loveday, Helen Cox, John Black, Mark P. Nicol, Lindy Dickson-Hall, C Grundy, Jeremy Hill, Alison D. Grant
Publikováno v:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 24(1)
SETTING: Thirteen districts in Eastern Cape (EC), KwaZulu-Natal (KZN) and Western Cape (WC) Provinces, South Africa.OBJECTIVE: To pilot a methodology for describing and visualising healthcare journeys among drug-resistant tuberculosis (DR-TB) patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa7f0ffb456398784443e445dfa55053
https://pubmed.ncbi.nlm.nih.gov/32005310
https://pubmed.ncbi.nlm.nih.gov/32005310
Autor:
Mark P. Nicol, Wendy S. Stevens, Frank Cobelens, Alison D. Grant, Lindy Dickson-Hall, Helen Cox, Norbert Ndjeka, Anja van’t Hoog
Publikováno v:
PLoS medicine, 14(2). Public Library of Science
PLoS Medicine
PLoS Medicine, Vol 14, Iss 2, p e1002238 (2017)
PLoS Medicine
PLoS Medicine, Vol 14, Iss 2, p e1002238 (2017)
Background South Africa has a large burden of rifampicin-resistant tuberculosis (RR-TB), with 18,734 patients diagnosed in 2014. The number of diagnosed patients has increased substantially with the introduction of the Xpert MTB/RIF test, used for tu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff33fafdbaafda8e5900c4a4aef65862
https://pure.amc.nl/en/publications/delays-and-loss-to-followup-before-treatment-of-drugresistant-tuberculosis-following-implementation-of-xpert-mtbrif-in-south-africa-a-retrospective-cohort-study(984c7cfc-9699-4ece-810f-11cd8f53d8d7).html
https://pure.amc.nl/en/publications/delays-and-loss-to-followup-before-treatment-of-drugresistant-tuberculosis-following-implementation-of-xpert-mtbrif-in-south-africa-a-retrospective-cohort-study(984c7cfc-9699-4ece-810f-11cd8f53d8d7).html